VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Sinusoidal obstruction syndrome in patients with R/R B-cell ALL

Valentín Ortiz-Maldonado • 1 Sep 2020
EBMT 2020
Acute Lymphoblastic Leukemia Leukemia ARI-0001 CAR-T Inotuzumab ozogamicin

Valentín Ortiz-Maldonado, MD, Hospital Clínic de Barcelona, Barcelona, Spain, discusses sinusoidal obstruction syndrome in patients with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (ALL) treated with ARI-0001 cells. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Valentín Ortiz-Maldonado

1:50
ICU admission of patients treated with ARI-0001 cells
Valentín Ortiz-Maldonado • 30 Jan 2020
1:42
Challenges associated with CAR-T cell production
Valentín Ortiz-Maldonado • 24 Aug 2020
3:04
ARI-0001 CART19 cells in R/R B-ALL with isolated extramedullary disease
Valentín Ortiz-Maldonado • 3 Feb 2021
1:05
ARI-0001 in CD19+ malignancies: next steps
Valentín Ortiz-Maldonado • 3 Feb 2021

Related Videos

6:57
Downregulation of HLA expression in acute leukemia relapsed after transplantation
Hui Wang • 17 Jun 2021
5:57
RIC transplant in CR1 for older AML patients
Nigel Russell • 15 Jun 2021
2:58
Evolution of the AML treatment paradigm
Nigel Russell • 15 Jun 2021
2:21
Post-transplant maintenance strategies in AML
Arnon Nagler • 14 Jun 2021
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals